TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22999065

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet + virgin olive oil
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet + nuts
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 110
Study: 21442804

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with massage
Number of subjects: 45

Group type: COMPARATOR
Intervention: Western medicine (Dexamethasone, Methotrexate, Prednisone)
Number of subjects: 45
Study: 19635128

Group type: EXPERIMENTAL
Intervention: web‐based problem solving through the internet (self‐examination therapy) without a coach
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: web‐based problem solving through the internet (self‐examination therapy) with the possibility to ask help from a coach on the initiative of the respondent (on demand, by email)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: web‐based problem solving through the internet (self‐examination therapy) with weekly scheduled contacts initiated by a coach (once per week, by email)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: weekly scheduled contacts initiated by a coach, but no web‐based intervention
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: information only (through the internet)
Number of subjects: 500

Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 500
Study: 16968364

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) program
Number of subjects: 107

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 107
Study: 14551133

Group type: EXPERIMENTAL
Intervention: hyper-CVAD and imatinib mesylate
Number of subjects: 20
Study: 11530042

Group type: EXPERIMENTAL
Intervention: ALT-trabeculectomy-trabeculectomy (ATT) sequence
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: trabeculectomy-ALT-trabeculectomy (TAT) sequence
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Both treatment sequences
Number of subjects: 657
Study: 9240732

Group type: EXPERIMENTAL
Intervention: Clodronate 300 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Etidronate 300 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Clodronate 150 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Clodronate 600 mg
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 7901952

Group type: EXPERIMENTAL
Intervention: Tandospirone (30 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam (5 mg)
Number of subjects: 12
Study: 3630823

Group type: EXPERIMENTAL
Intervention: Copper-containing IUDs (Nova-T, MLCu250, MLCu375)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Clomiphene stimulation
Number of subjects: 97
Study: 31926321

Group type: EXPERIMENTAL
Intervention: Hypnosis (HYP)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Education Control (EDU)
Number of subjects: 343
Study: 31397127

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with umbilical therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Montmorillonite powder (smecta)
Number of subjects: 120
Study: 28169553

Group type: EXPERIMENTAL
Intervention: Exercise plus health promotion intervention
Number of subjects: 0
Study: 25562712

Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox) 0.03 mg/kg/day
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox) 0.06 mg/kg/day
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 68
Study: 23280362

Group type: EXPERIMENTAL
Intervention: Reflection training (different version of DCCS with corrective feedback)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corrective feedback alone or mere practice with the task (control conditions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflection training (shortened 15min version)
Number of subjects: 0
Study: 21729487

Group type: EXPERIMENTAL
Intervention: Optimized diet (fermented soyabean and vitamin C-rich fruit)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 252
Study: 18304907

Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg/day, adjustable)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 16996843

Group type: EXPERIMENTAL
Intervention: Four IA courses at monthly intervals
Number of subjects: 22

Group type: COMPARATOR
Intervention: One IA course only
Number of subjects: 22
Study: 12850861

Group type: EXPERIMENTAL
Intervention: Alendronate 10mg/day
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg once a week
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Enteric alendronate 70 mg per week
Number of subjects: 75
Study: 10369728

Group type: COMPARATOR
Intervention: 1alpha-hydroxyvitamin D3 (1alpha(OH)D3) 1.0 microg/day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conjugated estrogens 0.625 mg/day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Combination of conjugated estrogens + 1alpha(OH)D3
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 79
Study: 8658369

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 160 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 240 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ipratropium bromide 40 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ipratropium bromide 80 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1867125

Group type: EXPERIMENTAL
Intervention: Oxiracetam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7055528

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg i.v.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.6 mg i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous work comparison
Number of subjects: 0
Study: 30957141

Group type: EXPERIMENTAL
Intervention: Purposeful sandbagging group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Word Memory EII
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Three Letters EII
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Composite score ≤1st percentile
Number of subjects: 77
Study: 30640204

Group type: EXPERIMENTAL
Intervention: d4T/3TC/EFV
Number of subjects: 536

Group type: COMPARATOR
Intervention: TDF/3TC/EFV
Number of subjects: 536
Study: 30223808

Group type: EXPERIMENTAL
Intervention: Community-based care with guardian-administered intramuscular injections
Number of subjects: 14

Group type: COMPARATOR
Intervention: Hospital-based care
Number of subjects: 14
Study: 26919207

Group type: EXPERIMENTAL
Intervention: Ciclosporin plus prednisolone
Number of subjects: 33

Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 33
Study: 24456512

Group type: EXPERIMENTAL
Intervention: 5-session, 4-week lifestyle intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 95
Study: 22833440

Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 60
Study: 20955955

Group type: EXPERIMENTAL
Intervention: GPX instruments (21-mm-long teeth)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GPX and xylol as solvent (21-mm-long teeth)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GPX instruments (25-mm-long teeth)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GPX and xylol as solvent (25-mm-long teeth)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hand files and xylol as solvent
Number of subjects: 50
Study: 17028126

Group type: EXPERIMENTAL
Intervention: OAC1W (1 week of omeprazole, amoxicillin, and clarithromycin)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: OAC2W (2 weeks of omeprazole, amoxicillin, and clarithromycin)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Omeprazole and amoxicillin (2 weeks)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: OAC2W
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: OAC1W
Number of subjects: 909
Study: 11092110

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate Easyhaler (BDP-EH)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Budesonide Turbohaler (BUD-TH)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 79
Study: 9305555

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 15
Study: 8348786

Group type: EXPERIMENTAL
Intervention: I2-NaF solution; administered six times to mothers' dentition.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo solution; administered six times to mothers' dentition.
Number of subjects: 48
Study: 3786637

Group type: EXPERIMENTAL
Intervention: Oral clonidine (0.15 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo controls
Number of subjects: 10
Study: 28844767

Group type: EXPERIMENTAL
Intervention: High-Flexion Mobile-Bearing TKA
Number of subjects: 92

Group type: COMPARATOR
Intervention: High-Flexion Fixed-Bearing TKA
Number of subjects: 92
Study: 27120807

Group type: EXPERIMENTAL
Intervention: CT plus Bev
Number of subjects: 289

Group type: COMPARATOR
Intervention: CT alone
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 289
Study: 25594352

Group type: EXPERIMENTAL
Intervention: rhuFVIIa infusion
Number of subjects: 84

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 84
Study: 23615461

Group type: EXPERIMENTAL
Intervention: R‐CHOP‐14 (intravenous cyclophosphamide 750 mg/m², doxorubicin 50 mg/m², vincristine 2 mg, rituximab 375 mg/m² on day 1, oral prednisolone 100 mg on days 1‐5, administered every 14 days for six cycles, followed by two further infusions of rituximab 375 mg/m² on day 1 every 14 days)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: R‐CHOP‐21 (intravenous cyclophosphamide 750 mg/m², doxorubicin 50 mg/m², vincristine 1.4 mg/m², rituximab 375 mg/m² on day 1, oral prednisolone 40 mg/m² on days 1‐5, administered every 21 days for a total of eight cycles)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: R‐CHOP‐14
Number of subjects: 1080

Group type: COMPARATOR
Intervention: R‐CHOP‐21
Number of subjects: 1080
Study: 20309699

Group type: EXPERIMENTAL
Intervention: Modern drug therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled drugs trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice registries
Number of subjects: 0
Study: 18845978

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 16619563

Group type: EXPERIMENTAL
Intervention: 10 KE of OK-432 (arm A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 1 KE of OK-432 (arm B)
Number of subjects: 38
Study: 14653278

Group type: EXPERIMENTAL
Intervention: Air abrasion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional rotary handpiece
Number of subjects: 10
Study: 8784622

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1% ophthalmic solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1617789

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary artery angioplasty (PTCA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conservative medical treatment
Number of subjects: 15
Study: 31645229

Group type: EXPERIMENTAL
Intervention: EDVIP (Emergency Department Violence Intervention Program)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 130
Study: 30355086

Group type: EXPERIMENTAL
Intervention: Immediate mechanical thrombectomy (MT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Best medical management (including rescue MT after neurological deterioration)
Number of subjects: 300
Study: 27197293

Group type: EXPERIMENTAL
Intervention: Low-dose exercise (150 min/wk; n = 44)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High-dose exercise (300 min/wk; n = 48)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (maintain usual activity levels; n = 45)
Number of subjects: 137
Study: 25209445

Group type: EXPERIMENTAL
Intervention: UCMSC transplantation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Self-healing
Number of subjects: 34
Study: 22858449

Group type: EXPERIMENTAL
Intervention: Active tobacco cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Passive tobacco cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Active e-cigarette smoking
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Passive e-cigarette smoking
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 30
Study: 20117915

Group type: EXPERIMENTAL
Intervention: Antibiotics administered on the first surgical visit, followed by placebo on the second visit after 3 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo administered on the first surgical visit, followed by antibiotics on the second visit after 3 weeks.
Number of subjects: 100
Study: 18952354

Group type: EXPERIMENTAL
Intervention: Medical Emergency Team (MET) system
Number of subjects: 3650

Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 3650
Study: 16632329

Group type: EXPERIMENTAL
Intervention: Ethyl-EPA 2g/day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 12831411

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 200/0.5
Number of subjects: 26

Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 26
Study: 11055152

Group type: EXPERIMENTAL
Intervention: Honest completion of noncognitive measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faking noncognitive measures
Number of subjects: 0
Study: 8781292

Group type: EXPERIMENTAL
Intervention: Neuropathic diabetic patients (IDDM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonneuropathic diabetic patients (IDDM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Neuropathic diabetic patients (NIDDM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nonneuropathic diabetic patients (NIDDM)
Number of subjects: 16
Study: 1478616

Group type: EXPERIMENTAL
Intervention: Arterialised venous blood (A Clamp)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Venous blood (V Clamp)
Number of subjects: 9
Study: 6088439

Group type: EXPERIMENTAL
Intervention: Purified concentrated bran product (FiberformR, 3.5 g) three times daily for 6 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 30886201

Group type: EXPERIMENTAL
Intervention: Intercropped with deficient nitrogen (50% N)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intercropped with adequate nitrogen (100% N)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Monocropped with deficient nitrogen (50% N)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Monocropped with adequate nitrogen (100% N)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Excessive nitrogen (150% N)
Number of subjects: 3
Study: 28612324

Group type: EXPERIMENTAL
Intervention: WhatsApp messaging (3 times a week for 4 weeks)
Number of subjects: 182

Group type: COMPARATOR
Intervention: PowerPoint presentation (weekly for 4 weeks)
Number of subjects: 182
Study: 26852040

Group type: EXPERIMENTAL
Intervention: Levofloxacin inhalation solution (APT-1026) 240mg BID for 28 days
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 24059674

Group type: EXPERIMENTAL
Intervention: 3D camera
Number of subjects: 24
Study: 23281860

Group type: EXPERIMENTAL
Intervention: Listening to preselected favorite music for 40 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting for the operation without music (Control)
Number of subjects: 60
Study: 20669632

Group type: EXPERIMENTAL
Intervention: New drugs and targeted therapies for high-risk groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: De-escalated treatment for better-defined low-risk groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive care (transfusions, antibiotics, pain control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specialized units and clinical research
Number of subjects: 0
Study: 18534221

Group type: EXPERIMENTAL
Intervention: 0.2 g/kg per day of PEG3350
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.4 g/kg per day of PEG3350
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg per day of PEG3350
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 16104914

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Naftopidil
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control (none)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Tamsulosin and Naftopidil (both)
Number of subjects: 185
Study: 11882400

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (jejunal tube feeding; Survimed OPD; 30 kcal/kg)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Early jejunal feeding combined with prophylactic imipenem (Tienam, 500 mg intravenously twice each day)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional parenteral nutrition (Rindex 10, Infusamin S, Intralipid 10%; 30 kcal/kg)
Number of subjects: 89
Study: 9932944

Group type: EXPERIMENTAL
Intervention: Active drug group (low-molecular weight heparinoid)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Overall effect of glucose on outcome
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Acute blood glucose level
Number of subjects: 1259
Study: 7503622

Group type: EXPERIMENTAL
Intervention: Nifedipine 40 mg/day
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Diltiazem 270 mg/day
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Diltiazem 240 to 360 mg/day
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg/day
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: High dose Verapamil 480 mg/day
Number of subjects: 241
Study: 2157737

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (0.25 x 10(4) PFU)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (0.5 x 10(4) PFU)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (10(4) PFU)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (all doses)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (medium and high doses)
Number of subjects: 130
Study: 6987185

Group type: EXPERIMENTAL
Intervention: Active powder containing undecylenic acid 2% and zinc undecylenate 20%
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 151
Study: 31852422

Group type: EXPERIMENTAL
Intervention: Baseline HbA1c levels
Number of subjects: 8145
Study: 31504106

Group type: EXPERIMENTAL
Intervention: Exercise (1 hour at 70% peak oxygen uptake)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (8 hours rest)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24
Study: 28544265

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) early group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) late group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Business as Usual (BAU)
Number of subjects: 60
Study: 25945260

Group type: EXPERIMENTAL
Intervention: Combined cognitive and physical training (8-week duration)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 70
Study: 23331949

Group type: EXPERIMENTAL
Intervention: ART48 (48 weeks antiretroviral therapy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ART12 (12 weeks antiretroviral therapy)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-treated control group
Number of subjects: 30
Study: 21216164

Group type: EXPERIMENTAL
Intervention: Eprinomectin (EPM) pour-on preparation at a dose of 0.5 mg/kg bodyweight
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (5 animals)
Number of subjects: 15
Study: 19861619

Group type: EXPERIMENTAL
Intervention: rDEN4Delta30‐4995
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 17710670

Group type: EXPERIMENTAL
Intervention: Breathing exercises with vagal biofeedback (6 breaths/min, 5 min each day for 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (received similar information and care)
Number of subjects: 40
Study: 15895315

Group type: EXPERIMENTAL
Intervention: Concentric training (CTG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Eccentric training (ETG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 15
Study: 11923161

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone valerate applied for three days followed by the base ointment for four days
Number of subjects: 207

Group type: COMPARATOR
Intervention: 1% hydrocortisone applied for seven days
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Both groups (0.1% betamethasone valerate and 1% hydrocortisone)
Number of subjects: 207
Study: 9799030

Group type: EXPERIMENTAL
Intervention: HRT group (N = 14), treated with 1 mg 17beta‐estradiol once daily and 5 or 10 mg dydrogesterone once daily during the third and fourth week of every 4 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: C-group (N = 15), which did not receive therapy
Number of subjects: 29
Study: 8563340

Group type: EXPERIMENTAL
Intervention: Expert system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booklet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 2391738

Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg twice daily
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 1000 mg twice daily
Number of subjects: 178
Study: 487880

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0